Ketamine for Depression: Where Do We Go from Here?
Summary & key facts
This paper looks at early research showing that a low dose of ketamine, given through a vein, can ease symptoms of hard-to-treat depression very fast — often within hours. The effect usually doesn't last long, and we still do not know if repeated use is safe or how best to give it. The authors say ketamine is a promising lead because it works differently from usual antidepressants, but stress we need larger, careful studies to learn who it helps, how to keep the benefit, and what risks it carries.
- Researchers reviewed early clinical studies where a single low dose of ketamine given into a vein reduced depressive symptoms within hours for people whose depression had not improved with other treatments.
- The antidepressant effect seen after a single ketamine dose typically wore off after about a week for many people.
- Short-term side effects of ketamine reported in studies include feeling disconnected from yourself or the world (called dissociation) and temporary rises in blood pressure.
- The long-term safety of repeated ketamine use for depression is not well known, and the best way to give repeated doses to keep benefits is still unclear.
- Ketamine appears to work differently from standard antidepressants; researchers think it changes brain chemical signaling and may help form new connections between brain cells, which could explain the rapid effect.
- The authors recommend more large, carefully controlled studies to test effectiveness, safety, ideal doses and schedules, and to find markers that predict who will benefit most.
Topics
Diet and metabolism studies Treatment of Major Depression Tryptophan and brain disordersCategories
Health Sciences Medicine PharmacologyTags
Depression (economics) Economics Ketamine Macroeconomics Medicine Psychiatry PsychologySubstances
KetamineConditions & symptoms
Depression Lack of energy or motivation Sadness or low moodReferencing articles
How Many Ketamine Treatments for Depression Are Needed?
The question on all the ketamine researchers’ lips right now is around the idea that…